<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Card Anaesth</journal-id><journal-id journal-id-type="iso-abbrev">Ann Card Anaesth</journal-id><journal-id journal-id-type="publisher-id">ACA</journal-id><journal-title-group><journal-title>Annals of Cardiac Anaesthesia</journal-title></journal-title-group><issn pub-type="ppub">0971-9784</issn><issn pub-type="epub">0974-5181</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26139740</article-id><article-id pub-id-type="pmc">4881703</article-id><article-id pub-id-type="publisher-id">ACA-18-352</article-id><article-id pub-id-type="doi">10.4103/0971-9784.159805</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparison of tapentadol with tramadol for analgesia after cardiac surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Iyer</surname><given-names>Srinivas Kalyanaraman</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>Mohan</surname><given-names>Gokulakrishnan</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Ramakrishnan</surname><given-names>Sivakumar</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Theodore</surname><given-names>Sanjay</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib></contrib-group><aff id="aff1">Department of Cardiac Anaesthesia, Chettinad Hospital and Research Institute, Kelambakkam, Chennai, Tamil Nadu, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Srinivas Kalyanaraman Iyer, Chettinad Hospital and Research Institute, Rajiv Gandhi Salai, Kelambakkam District, Chennai - 603 103, Tamil Nadu, India. E-mail: <email xlink:href="drks23814@yahoo.com">drks23814@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2015</year></pub-date><volume>18</volume><issue>3</issue><fpage>352</fpage><lpage>360</lpage><history><date date-type="received"><day>04</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>20</day><month>6</month><year>2015</year></date></history><permissions><copyright-statement>Copyright: © 2015 Annals of Cardiac Anaesthesia</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="3353" xml_f="3364" txt_i="11" txt_f="22">Background:</offsets></title><p><offsets xml_i="3375" xml_f="3504" txt_i="23" txt_f="152">Tapentadol is a relatively new analgesic. We decided to compare it with tramadol for their various effects after cardiac surgery.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3535" xml_f="3543" txt_i="154" txt_f="162">Setting:</offsets></title><p><offsets xml_i="3554" xml_f="3590" txt_i="163" txt_f="199">A study in a tertiary care hospital.</offsets></p></sec><sec id="st3"><title><offsets xml_i="3621" xml_f="3643" txt_i="201" txt_f="223">Materials and Methods:</offsets></title><p><offsets xml_i="3654" xml_f="4535" txt_i="224" txt_f="1105">Sixty adults undergoing cardiac surgery were divided into 2 groups of 30 each by computerized random allotment (Group X = tapentadol 50 mg oral and Group Y = tramadol 100 mg oral). Informed Consent and Institutional Ethics Committee approval were obtained. The patients were given either drug X or drug Y after extubation in this single blinded study, wherein the data collectors and analyzers were blinded to the study. All patients received oral paracetamol qds and either drug X or drug Y tds. The pain score was noted on a Visual Analog Scale before each drug dose, 3 h later and on coughing. Heart rate, respiratory rate, and blood pressure were recorded before the drug dose and 3 h later. Postoperative nausea or vomiting (PONV), temperature, and modified Glasgow Coma Scale readings were recorded. The above readings were obtained for 6 doses (up to 48 h after extubation).</offsets></p></sec><sec id="st4"><title><offsets xml_i="4566" xml_f="4577" txt_i="1107" txt_f="1118">Statistics:</offsets></title><p><italic><offsets xml_i="4596" xml_f="4597" txt_i="1119" txt_f="1120">t</offsets></italic><offsets xml_i="4606" xml_f="4707" txt_i="1120" txt_f="1221">-test, Pearson Chi-square test, Fisher exact test, and Mantel–Haenszel test were used for statistics.</offsets></p></sec><sec id="st5"><title><offsets xml_i="4738" xml_f="4746" txt_i="1223" txt_f="1231">Results:</offsets></title><p><offsets xml_i="4757" xml_f="5108" txt_i="1232" txt_f="1583">Tapentadol group patients had significantly better analgesia 3 h after the drug and “on coughing” than tramadol group. The difference in their effects on blood creatinine levels, temperature, hemodynamics, oxygen saturation, and respiratory rate were not clinically significant. Tapentadol produced lesser drowsiness and lesser vomiting than tramadol.</offsets></p></sec><sec id="st6"><title><offsets xml_i="5139" xml_f="5151" txt_i="1585" txt_f="1597">Conclusions:</offsets></title><p><offsets xml_i="5162" xml_f="5315" txt_i="1598" txt_f="1751">Tapentadol, due to its norepinephrine reuptake inhibition properties, in addition to mu agonist, is a better analgesic than tramadol and has lesser PONV.</offsets></p></sec></abstract><kwd-group><kwd>Analgesia</kwd><kwd>Tapentadol</kwd><kwd>Tramadol</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title><offsets xml_i="5489" xml_f="5501" txt_i="1760" txt_f="1772">INTRODUCTION</offsets></title><p><offsets xml_i="5512" xml_f="5736" txt_i="1773" txt_f="1997">Tramadol, a mu agonist, has been used for acute pain relief in the immediate postoperative period. Pain after cardiac surgery could be due to sternotomy, intercostal drain sites, or saphenous vein harvesting sites incisions.</offsets></p><p><offsets xml_i="5743" xml_f="6293" txt_i="1998" txt_f="2548">Pain management is an essential element of patient care. Active physiotherapy and cardiorespiratory rehabilitation help to reduce patient morbidity, anxiety, discomfort, and associated costs. Pain relief is an important aspect of rehabilitation. Multimodal approach to postoperative pain management have included the use of paracetamol, morphine through intravenous (IV) or patient-controlled analgesia (PCA) routes, nonsteroidal anti-inflammatory drugs (NSAIDs), local anesthetics, opioid analogs such as tramadol and regional anesthetic techniques.</offsets></p><p><offsets xml_i="6300" xml_f="6525" txt_i="2549" txt_f="2774">Tapentadol is a relatively new analgesic. It is a mu agonist and has additional norepinephrine reuptake inhibition properties. Tapentadol is reported to be an important addition in the management of moderate and severe pain.[</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="6558" xml_f="6559" txt_i="2774" txt_f="2775">1</offsets></xref><offsets xml_i="6566" xml_f="6763" txt_i="2775" txt_f="2972">] We decided to compare the effects of tapentadol with that of tramadol for analgesia in adult patients undergoing cardiac surgery. We also compared the effects of the two drugs on various systems.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="6826" xml_f="6847" txt_i="2974" txt_f="2995">MATERIALS AND METHODS</offsets></title><p><offsets xml_i="6858" xml_f="7363" txt_i="2996" txt_f="3501">A total of 60 patients undergoing cardiac surgery were divided into 2 groups of 30 each by computerized random allotment (Group X = tapentadol 50 mg oral 3 times daily [tds] or Group Y = tramadol 100 mg oral tds, total 6 doses of each, since the doses were equipotent). The study protocol was approved by our Institutional Ethics Committee. The study was conducted according to standards of good clinical practice. After explaining the details of the study, written consent was obtained from all patients.</offsets></p><p><offsets xml_i="7370" xml_f="8228" txt_i="3502" txt_f="4360">The patients were given either drug X or drug Y 1-h after extubation in this single blinded study, wherein the data collectors and data analyzers were blinded to the study. The nurse who administered the drug to the patient was different from the nurse who collected the data. The patients could not be blinded to the study for two reasons: (1) Oral tapentadol 50 mg was available as a white colored tablet, while two green colored capsules of tramadol, 50 mg each were needed to be administered for every dose. Thus, the color difference was recognizable. (2) If a study involves treatment in which active participation of the patient is necessary (e.g., physical therapy), then the participants cannot be easily blinded to the intervention. All 60 patients received oral paracetamol 650 mg 4 times daily. IV fentanyl 25–50 mcg/kg was used intraoperatively.</offsets></p><sec id="sec2-1"><title><offsets xml_i="8256" xml_f="8282" txt_i="4361" txt_f="4387">Patient selection criteria</offsets></title><p><offsets xml_i="8293" xml_f="8294" txt_i="4388" txt_f="4389">
</offsets><list list-type="bullet"><list-item><p><offsets xml_i="8333" xml_f="8653" txt_i="4389" txt_f="4709">Both males and females aged 18–65 years, weighing 40 kg or above, who were posted for cardiac surgery such as mitral valve replacement, coronary artery bypass graft surgery, atrial septal defect repair, and aortic valve replacement. Some of the patients undergoing coronary artery bypass graft surgery were done off-pump</offsets></p></list-item><list-item><p><offsets xml_i="8683" xml_f="8745" txt_i="4710" txt_f="4772">Those patients who gave written informed consent were studied.</offsets></p></list-item></list><offsets xml_i="8768" xml_f="8769" txt_i="4773" txt_f="4774">
</offsets></p></sec><sec id="sec2-2"><title><offsets xml_i="8803" xml_f="8829" txt_i="4776" txt_f="4802">Patient exclusion criteria</offsets></title><p><offsets xml_i="8840" xml_f="8882" txt_i="4803" txt_f="4845">Those who gave a history of the following:</offsets></p><p><offsets xml_i="8889" xml_f="8890" txt_i="4846" txt_f="4847">
</offsets><list list-type="bullet"><list-item><p><offsets xml_i="8929" xml_f="8987" txt_i="4847" txt_f="4905">Persistent nausea or vomiting at the time of randomization</offsets></p></list-item><list-item><p><offsets xml_i="9017" xml_f="9025" txt_i="4906" txt_f="4914">Epilepsy</offsets></p></list-item><list-item><p><offsets xml_i="9055" xml_f="9170" txt_i="4915" txt_f="5030">Treated with mono amino oxidase inhibitors, tricyclic antidepressants, serotonin norepinephrine reuptake inhibitors</offsets></p></list-item><list-item><p><offsets xml_i="9200" xml_f="9273" txt_i="5031" txt_f="5104">Traumatic brain injury, stroke, transient ischemic attack, or brain tumor</offsets></p></list-item><list-item><p><offsets xml_i="9303" xml_f="9313" txt_i="5105" txt_f="5115">Drug abuse</offsets></p></list-item><list-item><p><offsets xml_i="9343" xml_f="9380" txt_i="5116" txt_f="5153">Opioid tolerance or opioid dependence</offsets></p></list-item><list-item><p><offsets xml_i="9410" xml_f="9450" txt_i="5154" txt_f="5191">Renal disease (creatinine &gt;1.4 mg/dL)</offsets></p></list-item><list-item><p><offsets xml_i="9480" xml_f="9525" txt_i="5192" txt_f="5234">Liver disease (total bilirubin &gt;1.5 mg/dL)</offsets></p></list-item><list-item><p><offsets xml_i="9555" xml_f="9576" txt_i="5235" txt_f="5256">Allergies to any drug</offsets></p></list-item><list-item><p><offsets xml_i="9606" xml_f="9632" txt_i="5257" txt_f="5283">Major psychiatric disorder</offsets></p></list-item><list-item><p><offsets xml_i="9662" xml_f="9671" txt_i="5284" txt_f="5293">Pregnancy</offsets></p></list-item><list-item><p><offsets xml_i="9701" xml_f="9745" txt_i="5294" txt_f="5338">Preoperative intraaortic balloon pump (IABP)</offsets></p></list-item><list-item><p><offsets xml_i="9775" xml_f="9804" txt_i="5339" txt_f="5368">Preoperative vasoactive drugs</offsets></p></list-item><list-item><p><offsets xml_i="9834" xml_f="9855" txt_i="5369" txt_f="5390">Emergency surgery and</offsets></p></list-item><list-item><p><offsets xml_i="9885" xml_f="9967" txt_i="5391" txt_f="5473">Patients who were on high inotropic support and/or IABP at the time of extubation.</offsets></p></list-item></list><offsets xml_i="9990" xml_f="9991" txt_i="5474" txt_f="5475">
</offsets></p><p><offsets xml_i="9998" xml_f="10837" txt_i="5476" txt_f="6315">All the incisions were midline sternotomy. The pain score was noted on a Visual Analog Scale (VAS) before each drug dose, 3 h after the drug and “on coughing,” for 6 doses. Similarly heart rate, respiratory rate, systolic blood pressure (BP), diastolic BP, and oxygen saturation were recorded before the drug dose and 3 h later, for 6 doses. Postoperative nausea or vomiting (PONV) were recorded (if they occurred or not) after each dose. Patient's temperature was recorded 3 h and 5 h after administration of the drug. Modified Glasgow Coma Scale (GCS) was recorded 5 h after each drug dose. The blood creatinine levels were noted before the first dose, after dose 3, and after the sixth dose. Thus, the above readings were obtained for 48 h after extubation. The effects of the two drugs on any other body systems were noted and managed.</offsets></p><p><offsets xml_i="10844" xml_f="11905" txt_i="6316" txt_f="7377">A modified Wong-Baker Faces Scale (VAS) combined with a numeric pain rating scale (1–10) was used 1–4 was rated as mild pain, 5 and 6 were rated as moderate pain while 7–10 was rated as severe pain. The Pasero Sedation Scale was not used since it was not considered to be enough for our study purpose. The Pasero Scale has been used to titrate opioid dose (particularly IV dose) and naloxone dosage if there is a severe central nervous system (CNS) and/or respiratory depression. We wanted to grade “eye opening” as per our modified GCS. Hence, a modified GCS was used, wherein the best eye response and the best verbal response were recorded. It was decided that the best motor response will not be recorded since that may need a painful stimulus to elicit limb localization movement or withdrawal or flexion or extension. Richmond Agitation Sedation Score (RASS) has been used in other studies to monitor essentially patients on ventilator, those who are delirious and to scale their levels of restlessness and agitation. RASS was not applicable to our study.</offsets></p></sec><sec id="sec2-3"><title><offsets xml_i="11939" xml_f="11959" txt_i="7379" txt_f="7399">Statistical analysis</offsets></title><p><offsets xml_i="11970" xml_f="12054" txt_i="7400" txt_f="7484">IBM-SPSS (IBM Corporation, New York, United States) version 21 software was used. A </offsets><italic><offsets xml_i="12062" xml_f="12063" txt_i="7484" txt_f="7485">t</offsets></italic><offsets xml_i="12072" xml_f="12242" txt_i="7485" txt_f="7655">-test was used to compare the two mean values drawn from the same population. The null hypothesis was that the means of the two groups were the same. If the significance </offsets><italic><offsets xml_i="12250" xml_f="12251" txt_i="7655" txt_f="7656">P</offsets></italic><offsets xml_i="12260" xml_f="12312" txt_i="7656" txt_f="7708"> value was ≤ 0.05, the null hypothesis was rejected.</offsets></p><p><offsets xml_i="12319" xml_f="12505" txt_i="7709" txt_f="7895">The incidence of PONV among the two groups were compared using the Pearson Chi-square test. The significance value of the Chi-square test was 0.02, and the null hypothesis was rejected [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="12537" xml_f="12544" txt_i="7895" txt_f="7902">Table 1</offsets></xref><offsets xml_i="12551" xml_f="12553" txt_i="7902" txt_f="7904">].</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="12601" xml_f="12608" txt_i="7905" txt_f="7912">Table 1</offsets></label><caption><p><offsets xml_i="12628" xml_f="12648" txt_i="7912" txt_f="7932">PONV Chi-square test</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="6" rowspan="1"><offsets xml_i="12753" xml_f="12769" txt_i="7933" txt_f="7949">Chi-square tests</offsets></th></tr><tr><th align="center" colspan="6" rowspan="1"><hr></hr></th></tr><tr><th align="left" rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="12938" xml_f="12943" txt_i="7949" txt_f="7954">Value</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="12991" xml_f="12993" txt_i="7954" txt_f="7956">df</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="13041" xml_f="13075" txt_i="7956" txt_f="7990">Asymptotic significant (two-sided)</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="13123" xml_f="13152" txt_i="7990" txt_f="8019">Exact significant (two-sided)</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="13200" xml_f="13229" txt_i="8019" txt_f="8048">Exact significant (one-sided)</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="13299" xml_f="13317" txt_i="8048" txt_f="8066">Pearson Chi-square</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="13365" xml_f="13370" txt_i="8067" txt_f="8072">5.455</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="13418" xml_f="13419" txt_i="8073" txt_f="8074">1</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="13467" xml_f="13472" txt_i="8075" txt_f="8080">0.020</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="13623" xml_f="13642" txt_i="8083" txt_f="8102">Fisher’s exact test</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="13834" xml_f="13839" txt_i="8106" txt_f="8111">0.039</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="13887" xml_f="13892" txt_i="8112" txt_f="8117">0.020</offsets></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="13942" xml_f="14013" txt_i="8118" txt_f="8189">The significance value was 0.02. PONV: Postoperative nausea or vomiting</offsets></p></fn></table-wrap-foot></table-wrap><p><offsets xml_i="14056" xml_f="14352" txt_i="8190" txt_f="8483">Mantel-Haenszel test was used to assess the odds ratio (OR) of the two groups compared. An OR of &gt;1 indicates that the drug used increases the odds of recovery. The 95% confidence interval of the OR obtained were such that the lower bound limit was 1.20 while the upper bound limit was 15.60 [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="14384" xml_f="14391" txt_i="8483" txt_f="8490">Table 2</offsets></xref><offsets xml_i="14398" xml_f="14434" txt_i="8490" txt_f="8523">]. Thus, both the values were &gt;1.</offsets></p><table-wrap id="T2" position="float"><label><offsets xml_i="14482" xml_f="14489" txt_i="8524" txt_f="8531">Table 2</offsets></label><caption><p><offsets xml_i="14509" xml_f="14543" txt_i="8531" txt_f="8565">PONV - Mantel-Haenszel OR estimate</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="2" rowspan="1"><offsets xml_i="14648" xml_f="14682" txt_i="8566" txt_f="8600">Mantel-Haenszel common OR estimate</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="14752" xml_f="14760" txt_i="8600" txt_f="8608">Estimate</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="14808" xml_f="14813" txt_i="8609" txt_f="8614">4.333</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="14868" xml_f="14902" txt_i="8615" txt_f="8649">Asymptotic significant (two-sided)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="14950" xml_f="14955" txt_i="8650" txt_f="8655">0.025</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="15010" xml_f="15027" txt_i="8656" txt_f="8673">Asymptotic 95% CI</offsets></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="15130" xml_f="15140" txt_i="8675" txt_f="8685"> Common OR</offsets></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="15243" xml_f="15256" txt_i="8687" txt_f="8700">  Lower bound</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="15304" xml_f="15309" txt_i="8701" txt_f="8706">1.203</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="15364" xml_f="15377" txt_i="8707" txt_f="8720">  Upper bound</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="15425" xml_f="15431" txt_i="8721" txt_f="8727">15.605</offsets></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="15481" xml_f="15605" txt_i="8728" txt_f="8852">The 95% CI of the OR was from 1.20 to 15.60. OR: Odds ratio, CI: Confidence interval, PONV: Postoperative nausea or vomiting</offsets></p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="15700" xml_f="15707" txt_i="8855" txt_f="8862">RESULTS</offsets></title><p><offsets xml_i="15718" xml_f="15810" txt_i="8863" txt_f="8955">The two groups were similar in their body weight (in a kilogram) and age (in years) [Tables </offsets><xref ref-type="table" rid="T3"><offsets xml_i="15842" xml_f="15843" txt_i="8955" txt_f="8956">3</offsets></xref><offsets xml_i="15850" xml_f="15855" txt_i="8956" txt_f="8961"> and </offsets><xref ref-type="table" rid="T4"><offsets xml_i="15887" xml_f="15888" txt_i="8961" txt_f="8962">4</offsets></xref><offsets xml_i="15895" xml_f="16142" txt_i="8962" txt_f="9209">]. Mean weight (58.4 vs. 59.6) and mean age (41.1 vs. 40.4) between the two groups were statistically insignificant. There was a slight increase in the proportion of males in Group Y (tramadol) as compared with Group X (tapentadol) (73% vs. 60%) [</offsets><xref ref-type="table" rid="T5"><offsets xml_i="16174" xml_f="16181" txt_i="9209" txt_f="9216">Table 5</offsets></xref><offsets xml_i="16188" xml_f="16190" txt_i="9216" txt_f="9218">].</offsets></p><table-wrap id="T3" position="float"><label><offsets xml_i="16238" xml_f="16245" txt_i="9219" txt_f="9226">Table 3</offsets></label><caption><p><offsets xml_i="16265" xml_f="16284" txt_i="9226" txt_f="9245">Weight distribution</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="5" rowspan="1"><offsets xml_i="16389" xml_f="16414" txt_i="9246" txt_f="9271">Weight - group statistics</offsets></th><th align="center" colspan="2" rowspan="1"><offsets xml_i="16462" xml_f="16482" txt_i="9271" txt_f="9291">Independent samples </offsets><italic><offsets xml_i="16490" xml_f="16491" txt_i="9291" txt_f="9292">t</offsets></italic><offsets xml_i="16500" xml_f="16505" txt_i="9292" txt_f="9297">-test</offsets></th></tr><tr><th align="center" colspan="5" rowspan="1"><hr></hr></th><th align="center" colspan="2" rowspan="1"><hr></hr></th></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="16683" xml_f="16687" txt_i="9297" txt_f="9301">Drug</offsets></td><td align="center" rowspan="1" colspan="1"><italic><offsets xml_i="16743" xml_f="16744" txt_i="9302" txt_f="9303">n</offsets></italic></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16801" xml_f="16805" txt_i="9304" txt_f="9308">Mean</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16853" xml_f="16855" txt_i="9309" txt_f="9311">SD</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16903" xml_f="16906" txt_i="9312" txt_f="9315">SEM</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="16954" xml_f="16959" txt_i="9316" txt_f="9321">Value</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="17007" xml_f="17018" txt_i="9322" txt_f="9333">Significant</offsets></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="17088" xml_f="17089" txt_i="9334" txt_f="9335">Y</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="17137" xml_f="17139" txt_i="9336" txt_f="9338">30</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="17187" xml_f="17192" txt_i="9339" txt_f="9344">59.63</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="17240" xml_f="17246" txt_i="9345" txt_f="9351">10.858</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="17294" xml_f="17299" txt_i="9352" txt_f="9357">0.809</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="17347" xml_f="17352" txt_i="9358" txt_f="9363">1.039</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="17400" xml_f="17405" txt_i="9364" txt_f="9369">0.299</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="17460" xml_f="17461" txt_i="9370" txt_f="9371">X</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="17509" xml_f="17511" txt_i="9372" txt_f="9374">30</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="17559" xml_f="17564" txt_i="9375" txt_f="9380">58.43</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="17612" xml_f="17618" txt_i="9381" txt_f="9387">11.045</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="17666" xml_f="17671" txt_i="9388" txt_f="9393">0.823</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="17817" xml_f="17940" txt_i="9396" txt_f="9519">Mean weight was 59.6 kg in Group Y as compared with 58.4 kg in Group X. SD: Standard deviation, SEM: Standard error of mean</offsets></p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label><offsets xml_i="18024" xml_f="18031" txt_i="9520" txt_f="9527">Table 4</offsets></label><caption><p><offsets xml_i="18051" xml_f="18067" txt_i="9527" txt_f="9543">Age distribution</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="5" rowspan="1"><offsets xml_i="18172" xml_f="18194" txt_i="9544" txt_f="9566">Age - group statistics</offsets></th><th align="center" colspan="2" rowspan="1"><offsets xml_i="18242" xml_f="18262" txt_i="9566" txt_f="9586">Independent samples </offsets><italic><offsets xml_i="18270" xml_f="18271" txt_i="9586" txt_f="9587">t</offsets></italic><offsets xml_i="18280" xml_f="18285" txt_i="9587" txt_f="9592">-test</offsets></th></tr><tr><th align="center" colspan="5" rowspan="1"><hr></hr></th><th align="center" colspan="2" rowspan="1"><hr></hr></th></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="18463" xml_f="18467" txt_i="9592" txt_f="9596">Drug</offsets></td><td align="center" rowspan="1" colspan="1"><italic><offsets xml_i="18523" xml_f="18524" txt_i="9597" txt_f="9598">n</offsets></italic></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18581" xml_f="18589" txt_i="9599" txt_f="9607">Mean age</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18637" xml_f="18639" txt_i="9608" txt_f="9610">SD</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18687" xml_f="18690" txt_i="9611" txt_f="9614">SEM</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18738" xml_f="18743" txt_i="9615" txt_f="9620">Value</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18791" xml_f="18802" txt_i="9621" txt_f="9632">Significant</offsets></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="18872" xml_f="18873" txt_i="9633" txt_f="9634">Y</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18921" xml_f="18923" txt_i="9635" txt_f="9637">30</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="18971" xml_f="18976" txt_i="9638" txt_f="9643">40.40</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19024" xml_f="19030" txt_i="9644" txt_f="9650">14.521</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19078" xml_f="19083" txt_i="9651" txt_f="9656">2.651</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19131" xml_f="19137" txt_i="9657" txt_f="9663">−0.241</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19185" xml_f="19190" txt_i="9664" txt_f="9669">0.811</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="19245" xml_f="19246" txt_i="9670" txt_f="9671">X</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19294" xml_f="19296" txt_i="9672" txt_f="9674">30</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19344" xml_f="19349" txt_i="9675" txt_f="9680">41.13</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19397" xml_f="19402" txt_i="9681" txt_f="9686">8.203</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="19450" xml_f="19455" txt_i="9687" txt_f="9692">1.498</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="19601" xml_f="19727" txt_i="9695" txt_f="9821">Mean age was 40.4 years in Group Y as compared with 41.1 years in Group X. SD: Standard deviation, SEM: Standard error of mean</offsets></p></fn></table-wrap-foot></table-wrap><table-wrap id="T5" position="float"><label><offsets xml_i="19811" xml_f="19818" txt_i="9822" txt_f="9829">Table 5</offsets></label><caption><p><offsets xml_i="19838" xml_f="19857" txt_i="9829" txt_f="9848">Gender distribution</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" valign="top" colspan="1"><offsets xml_i="19973" xml_f="19976" txt_i="9849" txt_f="9852">Sex</offsets></th><th align="center" colspan="2" rowspan="1"><offsets xml_i="20024" xml_f="20030" txt_i="9852" txt_f="9858">Drug (</offsets><italic><offsets xml_i="20038" xml_f="20039" txt_i="9858" txt_f="9859">n</offsets></italic><offsets xml_i="20048" xml_f="20053" txt_i="9859" txt_f="9864"> (%))</offsets></th></tr><tr><th align="center" colspan="3" rowspan="1"><hr></hr></th></tr><tr><th align="center" rowspan="1" colspan="1"><offsets xml_i="20176" xml_f="20177" txt_i="9864" txt_f="9865">Y</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="20225" xml_f="20226" txt_i="9865" txt_f="9866">X</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="20296" xml_f="20300" txt_i="9866" txt_f="9870">Male</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="20348" xml_f="20358" txt_i="9871" txt_f="9881">22 (73.33)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="20406" xml_f="20416" txt_i="9882" txt_f="9892">18 (60.00)</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="20471" xml_f="20477" txt_i="9893" txt_f="9899">Female</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="20525" xml_f="20534" txt_i="9900" txt_f="9909">8 (26.67)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="20582" xml_f="20592" txt_i="9910" txt_f="9920">12 (40.00)</offsets></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="20642" xml_f="20724" txt_i="9921" txt_f="10003">About 60% of the patients in Group X and 73% of the patients in Group Y were males</offsets></p></fn></table-wrap-foot></table-wrap><p><offsets xml_i="20767" xml_f="21025" txt_i="10004" txt_f="10262">The mean VAS for pain at 3 h after the drug dose was significantly lesser in tapentadol group as compared with tramadol group (2.68 vs. 3.91). Similarly, the VAS on coughing was also lesser for the tapentadol group versus tramadol group (3.86 vs. 4.93). The </offsets><italic><offsets xml_i="21033" xml_f="21034" txt_i="10262" txt_f="10263">P</offsets></italic><offsets xml_i="21043" xml_f="21061" txt_i="10263" txt_f="10281"> value as per the </offsets><italic><offsets xml_i="21069" xml_f="21070" txt_i="10281" txt_f="10282">t</offsets></italic><offsets xml_i="21079" xml_f="21096" txt_i="10282" txt_f="10299">-test was 0.001 [</offsets><xref ref-type="table" rid="T6"><offsets xml_i="21128" xml_f="21135" txt_i="10299" txt_f="10306">Table 6</offsets></xref><offsets xml_i="21142" xml_f="21152" txt_i="10306" txt_f="10316">, Figures </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="21182" xml_f="21183" txt_i="10316" txt_f="10317">1</offsets></xref><offsets xml_i="21190" xml_f="21195" txt_i="10317" txt_f="10322"> and </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="21225" xml_f="21226" txt_i="10322" txt_f="10323">2</offsets></xref><offsets xml_i="21233" xml_f="21267" txt_i="10323" txt_f="10357">]. VAS before the drugs is as per </offsets><xref ref-type="fig" rid="F3"><offsets xml_i="21297" xml_f="21305" txt_i="10357" txt_f="10365">Figure 3</offsets></xref><offsets xml_i="21312" xml_f="21313" txt_i="10365" txt_f="10366">.</offsets></p><table-wrap id="T6" position="float"><label><offsets xml_i="21361" xml_f="21368" txt_i="10367" txt_f="10374">Table 6</offsets></label><caption><p><offsets xml_i="21388" xml_f="21469" txt_i="10374" txt_f="10455">VAS, heart rate, respiratory rate, BP, and oxygen saturation findings after the 3</offsets><sup><offsets xml_i="21474" xml_f="21476" txt_i="10455" txt_f="10457">rd</offsets></sup><offsets xml_i="21482" xml_f="21487" txt_i="10457" txt_f="10462"> dose</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="5" valign="top" colspan="1"><offsets xml_i="21605" xml_f="21609" txt_i="10463" txt_f="10467">Dose</offsets></th><th align="center" rowspan="5" valign="top" colspan="1"><offsets xml_i="21670" xml_f="21680" txt_i="10467" txt_f="10477">Parameters</offsets></th><th align="center" colspan="4" rowspan="1"><offsets xml_i="21728" xml_f="21732" txt_i="10477" txt_f="10481">Drug</offsets></th><th align="center" colspan="2" rowspan="1"><offsets xml_i="21780" xml_f="21800" txt_i="10481" txt_f="10501">Independent samples </offsets><italic><offsets xml_i="21808" xml_f="21809" txt_i="10501" txt_f="10502">t</offsets></italic><offsets xml_i="21818" xml_f="21823" txt_i="10502" txt_f="10507">-test</offsets></th></tr><tr><th align="center" colspan="4" rowspan="1"><hr></hr></th></tr><tr><th align="center" colspan="2" rowspan="1"><offsets xml_i="21946" xml_f="21947" txt_i="10507" txt_f="10508">Y</offsets></th><th align="center" colspan="2" rowspan="1"><offsets xml_i="21995" xml_f="21996" txt_i="10508" txt_f="10509">X</offsets></th></tr><tr><th align="center" colspan="2" rowspan="1"><hr></hr></th><th align="center" colspan="2" rowspan="1"><hr></hr></th><th align="center" colspan="2" rowspan="1"><hr></hr></th></tr><tr><th align="left" rowspan="1" colspan="1"><offsets xml_i="22231" xml_f="22235" txt_i="10509" txt_f="10513">Mean</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="22283" xml_f="22285" txt_i="10513" txt_f="10515">SD</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="22333" xml_f="22337" txt_i="10515" txt_f="10519">Mean</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="22385" xml_f="22387" txt_i="10519" txt_f="10521">SD</offsets></th><th align="center" rowspan="1" colspan="1"><italic><offsets xml_i="22443" xml_f="22444" txt_i="10521" txt_f="10522">t</offsets></italic><offsets xml_i="22453" xml_f="22458" txt_i="10522" txt_f="10527">-test</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="22506" xml_f="22517" txt_i="10527" txt_f="10538">Significant</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="22587" xml_f="22588" txt_i="10538" txt_f="10539">3</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="22634" xml_f="22649" txt_i="10540" txt_f="10555">VAS-before drug</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="22697" xml_f="22701" txt_i="10556" txt_f="10560">5.42</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="22749" xml_f="22753" txt_i="10561" txt_f="10565">1.11</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="22801" xml_f="22805" txt_i="10566" txt_f="10570">4.91</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="22853" xml_f="22857" txt_i="10571" txt_f="10575">1.40</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="22905" xml_f="22910" txt_i="10576" txt_f="10581">1.564</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="22958" xml_f="22963" txt_i="10582" txt_f="10587">0.123</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="23064" xml_f="23071" txt_i="10589" txt_f="10596">VAS-3 h</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23119" xml_f="23123" txt_i="10597" txt_f="10601">3.91</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23171" xml_f="23175" txt_i="10602" txt_f="10606">1.01</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23223" xml_f="23227" txt_i="10607" txt_f="10611">2.68</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23275" xml_f="23279" txt_i="10612" txt_f="10616">1.27</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23327" xml_f="23332" txt_i="10617" txt_f="10622">4.163</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23380" xml_f="23385" txt_i="10623" txt_f="10628">0.000</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="23486" xml_f="23501" txt_i="10630" txt_f="10645">VAS-on coughing</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23549" xml_f="23553" txt_i="10646" txt_f="10650">4.93</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23601" xml_f="23605" txt_i="10651" txt_f="10655">1.04</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23653" xml_f="23657" txt_i="10656" txt_f="10660">3.86</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23705" xml_f="23709" txt_i="10661" txt_f="10665">1.31</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23757" xml_f="23762" txt_i="10666" txt_f="10671">3.482</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23810" xml_f="23815" txt_i="10672" txt_f="10677">0.001</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="23916" xml_f="23926" txt_i="10679" txt_f="10689">Heart rate</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="23974" xml_f="23979" txt_i="10690" txt_f="10695">91.37</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24027" xml_f="24032" txt_i="10696" txt_f="10701">16.42</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24080" xml_f="24085" txt_i="10702" txt_f="10707">92.87</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24133" xml_f="24138" txt_i="10708" txt_f="10713">13.32</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24186" xml_f="24192" txt_i="10714" txt_f="10720">−0.389</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24240" xml_f="24245" txt_i="10721" txt_f="10726">0.699</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="24346" xml_f="24362" txt_i="10728" txt_f="10744">Respiratory rate</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24410" xml_f="24415" txt_i="10745" txt_f="10750">21.40</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24463" xml_f="24467" txt_i="10751" txt_f="10755">2.36</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24515" xml_f="24520" txt_i="10756" txt_f="10761">21.87</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24568" xml_f="24572" txt_i="10762" txt_f="10766">2.57</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24620" xml_f="24626" txt_i="10767" txt_f="10773">−0.733</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24674" xml_f="24679" txt_i="10774" txt_f="10779">0.467</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="24780" xml_f="24791" txt_i="10781" txt_f="10792">Systolic BP</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24839" xml_f="24845" txt_i="10793" txt_f="10799">115.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24893" xml_f="24898" txt_i="10800" txt_f="10805">11.90</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="24946" xml_f="24952" txt_i="10806" txt_f="10812">116.90</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25000" xml_f="25005" txt_i="10813" txt_f="10818">12.64</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25053" xml_f="25059" txt_i="10819" txt_f="10825">−0.600</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25107" xml_f="25112" txt_i="10826" txt_f="10831">0.551</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="25213" xml_f="25225" txt_i="10833" txt_f="10845">Diastolic BP</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25273" xml_f="25278" txt_i="10846" txt_f="10851">61.23</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25326" xml_f="25330" txt_i="10852" txt_f="10856">7.50</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25378" xml_f="25383" txt_i="10857" txt_f="10862">62.33</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25431" xml_f="25435" txt_i="10863" txt_f="10867">9.43</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25483" xml_f="25489" txt_i="10868" txt_f="10874">−0.500</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25537" xml_f="25542" txt_i="10875" txt_f="10880">0.619</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="25643" xml_f="25646" txt_i="10882" txt_f="10885">SpO</offsets><sub><offsets xml_i="25651" xml_f="25652" txt_i="10885" txt_f="10886">2</offsets></sub><offsets xml_i="25658" xml_f="25662" txt_i="10886" txt_f="10890"> (%)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25710" xml_f="25714" txt_i="10891" txt_f="10895">1.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25762" xml_f="25766" txt_i="10896" txt_f="10900">0.01</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25814" xml_f="25818" txt_i="10901" txt_f="10905">1.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25866" xml_f="25870" txt_i="10906" txt_f="10910">0.01</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25918" xml_f="25923" txt_i="10911" txt_f="10916">1.022</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="25971" xml_f="25976" txt_i="10917" txt_f="10922">0.311</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="26077" xml_f="26086" txt_i="10924" txt_f="10933">After 3 h</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="26475" xml_f="26485" txt_i="10941" txt_f="10951">Heart rate</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="26533" xml_f="26538" txt_i="10952" txt_f="10957">90.97</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="26586" xml_f="26591" txt_i="10958" txt_f="10963">15.83</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="26639" xml_f="26644" txt_i="10964" txt_f="10969">92.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="26692" xml_f="26697" txt_i="10970" txt_f="10975">13.02</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="26745" xml_f="26751" txt_i="10976" txt_f="10982">−0.276</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="26799" xml_f="26804" txt_i="10983" txt_f="10988">0.783</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="26905" xml_f="26921" txt_i="10990" txt_f="11006">Respiratory rate</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="26969" xml_f="26974" txt_i="11007" txt_f="11012">21.27</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27022" xml_f="27026" txt_i="11013" txt_f="11017">2.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27074" xml_f="27079" txt_i="11018" txt_f="11023">26.10</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27127" xml_f="27132" txt_i="11024" txt_f="11029">17.45</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27180" xml_f="27187" txt_i="11030" txt_f="11037">−01.508</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27235" xml_f="27240" txt_i="11038" txt_f="11043">0.142</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="27341" xml_f="27352" txt_i="11045" txt_f="11056">Systolic BP</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27400" xml_f="27406" txt_i="11057" txt_f="11063">114.40</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27454" xml_f="27459" txt_i="11064" txt_f="11069">14.15</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27507" xml_f="27513" txt_i="11070" txt_f="11076">116.97</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27561" xml_f="27566" txt_i="11077" txt_f="11082">12.63</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27614" xml_f="27620" txt_i="11083" txt_f="11089">−0.741</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27668" xml_f="27673" txt_i="11090" txt_f="11095">0.461</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="27774" xml_f="27786" txt_i="11097" txt_f="11109">Diastolic BP</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27834" xml_f="27839" txt_i="11110" txt_f="11115">60.87</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27887" xml_f="27891" txt_i="11116" txt_f="11120">7.74</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27939" xml_f="27944" txt_i="11121" txt_f="11126">62.60</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="27992" xml_f="27996" txt_i="11127" txt_f="11131">9.64</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28044" xml_f="28050" txt_i="11132" txt_f="11138">−0.768</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28098" xml_f="28103" txt_i="11139" txt_f="11144">0.446</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="28204" xml_f="28207" txt_i="11146" txt_f="11149">SpO</offsets><sub><offsets xml_i="28212" xml_f="28213" txt_i="11149" txt_f="11150">2</offsets></sub></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28267" xml_f="28271" txt_i="11151" txt_f="11155">1.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28319" xml_f="28323" txt_i="11156" txt_f="11160">0.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28371" xml_f="28375" txt_i="11161" txt_f="11165">0.99</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28423" xml_f="28427" txt_i="11166" txt_f="11170">0.05</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28475" xml_f="28480" txt_i="11171" txt_f="11176">1.419</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28528" xml_f="28533" txt_i="11177" txt_f="11182">0.166</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="28634" xml_f="28645" txt_i="11184" txt_f="11195">Temperature</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28693" xml_f="28698" txt_i="11196" txt_f="11201">99.41</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28746" xml_f="28750" txt_i="11202" txt_f="11206">1.05</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28798" xml_f="28803" txt_i="11207" txt_f="11212">98.98</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28851" xml_f="28855" txt_i="11213" txt_f="11217">0.71</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28903" xml_f="28908" txt_i="11218" txt_f="11223">0.708</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="28956" xml_f="28961" txt_i="11224" txt_f="11229">0.506</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="29062" xml_f="29083" txt_i="11231" txt_f="11252">Temperature after 3 h</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="29131" xml_f="29136" txt_i="11253" txt_f="11258">97.62</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="29184" xml_f="29188" txt_i="11259" txt_f="11263">6.30</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="29236" xml_f="29241" txt_i="11264" txt_f="11269">99.11</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="29289" xml_f="29293" txt_i="11270" txt_f="11274">2.17</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="29341" xml_f="29347" txt_i="11275" txt_f="11281">−1.226</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="29395" xml_f="29400" txt_i="11282" txt_f="11287">0.225</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="29501" xml_f="29522" txt_i="11289" txt_f="11310">Temperature after 5 h</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="29570" xml_f="29575" txt_i="11311" txt_f="11316">98.05</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="29623" xml_f="29627" txt_i="11317" txt_f="11321">4.38</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="29675" xml_f="29680" txt_i="11322" txt_f="11327">98.67</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="29728" xml_f="29732" txt_i="11328" txt_f="11332">0.42</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="29780" xml_f="29786" txt_i="11333" txt_f="11339">−0.762</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="29834" xml_f="29839" txt_i="11340" txt_f="11345">0.449</offsets></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="29889" xml_f="29967" txt_i="11346" txt_f="11424">The above findings were noted before the drug, on coughing and 3 h after the 3</offsets><sup><offsets xml_i="29972" xml_f="29974" txt_i="11424" txt_f="11426">rd</offsets></sup><offsets xml_i="29980" xml_f="30238" txt_i="11426" txt_f="11684"> dose of the drug. Similarly, readings were obtained for the two groups after the doses 1, 2, 4, 5, and 6. The oxygen saturation values obtained were divided by 100 for statistical purpose. VAS: Visual Analog Scale, BP: Blood pressure, SD: Standard deviation</offsets></p></fn></table-wrap-foot></table-wrap><fig id="F1" position="float"><label><offsets xml_i="30315" xml_f="30323" txt_i="11685" txt_f="11693">Figure 1</offsets></label><caption><p><offsets xml_i="30343" xml_f="30439" txt_i="11693" txt_f="11789">Mean Visual Analog Scale at 3 h after the drug Y is compared with that of drug X for the 6 doses</offsets></p></caption><graphic xlink:href="ACA-18-352-g001"></graphic></fig><fig id="F2" position="float"><label><offsets xml_i="30544" xml_f="30552" txt_i="11790" txt_f="11798">Figure 2</offsets></label><caption><p><offsets xml_i="30572" xml_f="30673" txt_i="11798" txt_f="11899">Mean Visual Analog Scale on coughing after the drug Y is compared with that of drug X for the 6 doses</offsets></p></caption><graphic xlink:href="ACA-18-352-g002"></graphic></fig><fig id="F3" position="float"><label><offsets xml_i="30778" xml_f="30786" txt_i="11900" txt_f="11908">Figure 3</offsets></label><caption><p><offsets xml_i="30806" xml_f="30900" txt_i="11908" txt_f="12002">Mean Visual Analog Scale before the drug dose for both the groups are compared for the 6 doses</offsets></p></caption><graphic xlink:href="ACA-18-352-g003"></graphic></fig><p><offsets xml_i="30971" xml_f="31132" txt_i="12003" txt_f="12164">The oxygen saturation (in percentage divided by 100), heart rate, respiratory rate, BP, and temperature were not significantly different between the two groups [</offsets><xref ref-type="table" rid="T6"><offsets xml_i="31164" xml_f="31171" txt_i="12164" txt_f="12171">Table 6</offsets></xref><offsets xml_i="31178" xml_f="31180" txt_i="12171" txt_f="12173">].</offsets></p><p><offsets xml_i="31187" xml_f="31349" txt_i="12174" txt_f="12336">The mean creatinine levels (mg/dL) ranged from 1 to 1.2 for tapentadol group versus 1.05 to 1.15 for tramadol group and were thus similar between the two groups [</offsets><xref ref-type="fig" rid="F4"><offsets xml_i="31379" xml_f="31387" txt_i="12336" txt_f="12344">Figure 4</offsets></xref><offsets xml_i="31394" xml_f="31396" txt_i="12344" txt_f="12346">].</offsets></p><fig id="F4" position="float"><label><offsets xml_i="31437" xml_f="31445" txt_i="12347" txt_f="12355">Figure 4</offsets></label><caption><p><offsets xml_i="31465" xml_f="31525" txt_i="12355" txt_f="12415">Mean blood creatinine levels for the two groups are compared</offsets></p></caption><graphic xlink:href="ACA-18-352-g004"></graphic></fig><p><offsets xml_i="31596" xml_f="31706" txt_i="12416" txt_f="12526">PONV occurred in 4 out of 30 tapentadol group patients as compared with 12 out of 30 tramadol group patients [</offsets><xref ref-type="table" rid="T7"><offsets xml_i="31738" xml_f="31745" txt_i="12526" txt_f="12533">Table 7</offsets></xref><offsets xml_i="31752" xml_f="31876" txt_i="12533" txt_f="12657">]. Postoperative nausea was noted after 22 out of 180 tramadol doses as compared with 5 out of 180 tapentadol doses.[Tables </offsets><xref ref-type="table" rid="T8"><offsets xml_i="31908" xml_f="31909" txt_i="12657" txt_f="12658">8</offsets></xref><offsets xml_i="31916" xml_f="31921" txt_i="12658" txt_f="12663"> and </offsets><xref ref-type="table" rid="T9"><offsets xml_i="31953" xml_f="31954" txt_i="12663" txt_f="12664">9</offsets></xref><offsets xml_i="31961" xml_f="32098" txt_i="12664" txt_f="12801">]. Similarly, postoperative vomiting was noted after 17 out of 180 tramadol doses as compared with 2 out of 180 tapentadol doses [Tables </offsets><xref ref-type="table" rid="T8"><offsets xml_i="32130" xml_f="32131" txt_i="12801" txt_f="12802">8</offsets></xref><offsets xml_i="32138" xml_f="32143" txt_i="12802" txt_f="12807"> and </offsets><xref ref-type="table" rid="T9"><offsets xml_i="32175" xml_f="32176" txt_i="12807" txt_f="12808">9</offsets></xref><offsets xml_i="32183" xml_f="32185" txt_i="12808" txt_f="12810">].</offsets></p><table-wrap id="T7" position="float"><label><offsets xml_i="32233" xml_f="32240" txt_i="12811" txt_f="12818">Table 7</offsets></label><caption><p><offsets xml_i="32260" xml_f="32273" txt_i="12818" txt_f="12831">PONV findings</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="4" rowspan="1"><offsets xml_i="32378" xml_f="32424" txt_i="12832" txt_f="12878">Drug * nausea and/or vomiting cross tabulation</offsets></th></tr><tr><th align="center" colspan="4" rowspan="1"><hr></hr></th></tr><tr><th align="left" rowspan="3" valign="top" colspan="1"><offsets xml_i="32558" xml_f="32562" txt_i="12878" txt_f="12882">Drug</offsets></th><th align="center" colspan="2" rowspan="1"><offsets xml_i="32610" xml_f="32632" txt_i="12882" txt_f="12904">Nausea and/or vomiting</offsets></th><th align="center" rowspan="3" valign="top" colspan="1"><offsets xml_i="32693" xml_f="32698" txt_i="12904" txt_f="12909">Total</offsets></th></tr><tr><th align="center" colspan="2" rowspan="1"><hr></hr></th><th align="center" colspan="2" rowspan="1"><hr></hr></th></tr><tr><th align="center" rowspan="1" colspan="1"><offsets xml_i="32878" xml_f="32881" txt_i="12909" txt_f="12912">Yes</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="32929" xml_f="32931" txt_i="12912" txt_f="12914">No</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="33001" xml_f="33002" txt_i="12914" txt_f="12915">Y</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="33201" xml_f="33207" txt_i="12919" txt_f="12925"> Count</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="33255" xml_f="33257" txt_i="12926" txt_f="12928">12</offsets><sup><offsets xml_i="33262" xml_f="33263" txt_i="12928" txt_f="12929">a</offsets></sup></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="33317" xml_f="33319" txt_i="12930" txt_f="12932">18</offsets><sup><offsets xml_i="33324" xml_f="33325" txt_i="12932" txt_f="12933">b</offsets></sup></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="33379" xml_f="33381" txt_i="12934" txt_f="12936">30</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="33436" xml_f="33442" txt_i="12937" txt_f="12943"> Row %</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="33490" xml_f="33495" txt_i="12944" txt_f="12949">40.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="33543" xml_f="33548" txt_i="12950" txt_f="12955">60.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="33596" xml_f="33602" txt_i="12956" txt_f="12962">100.00</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="33657" xml_f="33666" txt_i="12963" txt_f="12972"> Column %</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="33714" xml_f="33719" txt_i="12973" txt_f="12978">75.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="33767" xml_f="33772" txt_i="12979" txt_f="12984">40.91</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="33820" xml_f="33825" txt_i="12985" txt_f="12990">50.00</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="33880" xml_f="33881" txt_i="12991" txt_f="12992">X</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="34080" xml_f="34086" txt_i="12996" txt_f="13002"> Count</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="34134" xml_f="34135" txt_i="13003" txt_f="13004">4</offsets><sup><offsets xml_i="34140" xml_f="34141" txt_i="13004" txt_f="13005">a</offsets></sup></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="34195" xml_f="34197" txt_i="13006" txt_f="13008">26</offsets><sup><offsets xml_i="34202" xml_f="34203" txt_i="13008" txt_f="13009">b</offsets></sup></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="34257" xml_f="34259" txt_i="13010" txt_f="13012">30</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="34314" xml_f="34320" txt_i="13013" txt_f="13019"> Row %</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="34368" xml_f="34373" txt_i="13020" txt_f="13025">13.33</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="34421" xml_f="34426" txt_i="13026" txt_f="13031">86.67</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="34474" xml_f="34480" txt_i="13032" txt_f="13038">100.00</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="34535" xml_f="34544" txt_i="13039" txt_f="13048"> Column %</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="34592" xml_f="34597" txt_i="13049" txt_f="13054">25.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="34645" xml_f="34650" txt_i="13055" txt_f="13060">59.09</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="34698" xml_f="34703" txt_i="13061" txt_f="13066">50.00</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="34758" xml_f="34763" txt_i="13067" txt_f="13072">Total</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="34962" xml_f="34968" txt_i="13076" txt_f="13082"> Count</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="35016" xml_f="35018" txt_i="13083" txt_f="13085">16</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="35066" xml_f="35068" txt_i="13086" txt_f="13088">44</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="35116" xml_f="35118" txt_i="13089" txt_f="13091">60</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="35173" xml_f="35179" txt_i="13092" txt_f="13098"> Row %</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="35227" xml_f="35232" txt_i="13099" txt_f="13104">26.67</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="35280" xml_f="35285" txt_i="13105" txt_f="13110">73.33</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="35333" xml_f="35339" txt_i="13111" txt_f="13117">100.00</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="35394" xml_f="35403" txt_i="13118" txt_f="13127"> Column %</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="35451" xml_f="35457" txt_i="13128" txt_f="13134">100.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="35505" xml_f="35511" txt_i="13135" txt_f="13141">100.00</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="35559" xml_f="35565" txt_i="13142" txt_f="13148">100.00</offsets></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="35615" xml_f="35735" txt_i="13149" txt_f="13269">4 out of 30 patients in Group X versus 12 out of 30 patients in Group Y had PONV. PONV: Postoperative nausea or vomiting</offsets></p></fn></table-wrap-foot></table-wrap><table-wrap id="T8" position="float"><label><offsets xml_i="35819" xml_f="35826" txt_i="13270" txt_f="13277">Table 8</offsets></label><caption><p><offsets xml_i="35846" xml_f="35885" txt_i="13277" txt_f="13316">PONV findings after each dose of drug Y</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" valign="top" colspan="1"><offsets xml_i="36001" xml_f="36005" txt_i="13317" txt_f="13321">Drug</offsets></th><th align="center" colspan="6" rowspan="1"><offsets xml_i="36053" xml_f="36059" txt_i="13321" txt_f="13327">Dose (</offsets><italic><offsets xml_i="36067" xml_f="36068" txt_i="13327" txt_f="13328">n</offsets></italic><offsets xml_i="36077" xml_f="36082" txt_i="13328" txt_f="13333"> (%))</offsets></th></tr><tr><th align="center" colspan="7" rowspan="1"><hr></hr></th></tr><tr><th align="center" rowspan="1" colspan="1"><offsets xml_i="36205" xml_f="36206" txt_i="13333" txt_f="13334">1</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="36254" xml_f="36255" txt_i="13334" txt_f="13335">2</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="36303" xml_f="36304" txt_i="13335" txt_f="13336">3</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="36352" xml_f="36353" txt_i="13336" txt_f="13337">4</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="36401" xml_f="36402" txt_i="13337" txt_f="13338">5</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="36450" xml_f="36451" txt_i="13338" txt_f="13339">6</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="36521" xml_f="36522" txt_i="13339" txt_f="13340">Y</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="36865" xml_f="36872" txt_i="13347" txt_f="13354"> Nausea</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="37215" xml_f="37220" txt_i="13361" txt_f="13366">  Yes</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="37268" xml_f="37277" txt_i="13367" txt_f="13376">6 (20.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="37325" xml_f="37333" txt_i="13377" txt_f="13385">2 (6.67)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="37381" xml_f="37389" txt_i="13386" txt_f="13394">2 (6.67)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="37437" xml_f="37446" txt_i="13395" txt_f="13404">6 (20.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="37494" xml_f="37503" txt_i="13405" txt_f="13414">4 (13.33)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="37551" xml_f="37559" txt_i="13415" txt_f="13423">2 (6.67)</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="37614" xml_f="37618" txt_i="13424" txt_f="13428">  No</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="37666" xml_f="37676" txt_i="13429" txt_f="13439">24 (80.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="37724" xml_f="37734" txt_i="13440" txt_f="13450">28 (93.33)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="37782" xml_f="37792" txt_i="13451" txt_f="13461">28 (93.33)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="37840" xml_f="37850" txt_i="13462" txt_f="13472">24 (80.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="37898" xml_f="37908" txt_i="13473" txt_f="13483">26 (86.67)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="37956" xml_f="37966" txt_i="13484" txt_f="13494">28 (93.33)</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="38021" xml_f="38030" txt_i="13495" txt_f="13504"> Vomiting</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="38373" xml_f="38378" txt_i="13511" txt_f="13516">  Yes</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38426" xml_f="38435" txt_i="13517" txt_f="13526">3 (10.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38483" xml_f="38492" txt_i="13527" txt_f="13536">3 (10.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38540" xml_f="38549" txt_i="13537" txt_f="13546">3 (10.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38597" xml_f="38606" txt_i="13547" txt_f="13556">3 (10.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38654" xml_f="38663" txt_i="13557" txt_f="13566">3 (10.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38711" xml_f="38719" txt_i="13567" txt_f="13575">2 (6.67)</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="38774" xml_f="38778" txt_i="13576" txt_f="13580">  No</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38826" xml_f="38836" txt_i="13581" txt_f="13591">27 (90.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38884" xml_f="38894" txt_i="13592" txt_f="13602">27 (90.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="38942" xml_f="38952" txt_i="13603" txt_f="13613">27 (90.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39000" xml_f="39010" txt_i="13614" txt_f="13624">27 (90.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39058" xml_f="39068" txt_i="13625" txt_f="13635">27 (90.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="39116" xml_f="39126" txt_i="13636" txt_f="13646">28 (93.33)</offsets></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="39176" xml_f="39323" txt_i="13647" txt_f="13794">Nausea was noted after 22 out of 180 drug Y doses while vomiting was noted after 17 out of 180 drug Y doses. PONV: Postoperative nausea or vomiting</offsets></p></fn></table-wrap-foot></table-wrap><table-wrap id="T9" position="float"><label><offsets xml_i="39407" xml_f="39414" txt_i="13795" txt_f="13802">Table 9</offsets></label><caption><p><offsets xml_i="39434" xml_f="39473" txt_i="13802" txt_f="13841">PONV findings after each dose of drug X</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" valign="top" colspan="1"><offsets xml_i="39589" xml_f="39593" txt_i="13842" txt_f="13846">Drug</offsets></th><th align="center" colspan="6" rowspan="1"><offsets xml_i="39641" xml_f="39647" txt_i="13846" txt_f="13852">Dose (</offsets><italic><offsets xml_i="39655" xml_f="39656" txt_i="13852" txt_f="13853">n</offsets></italic><offsets xml_i="39665" xml_f="39670" txt_i="13853" txt_f="13858"> (%))</offsets></th></tr><tr><th align="center" colspan="7" rowspan="1"><hr></hr></th></tr><tr><th align="center" rowspan="1" colspan="1"><offsets xml_i="39793" xml_f="39794" txt_i="13858" txt_f="13859">1</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="39842" xml_f="39843" txt_i="13859" txt_f="13860">2</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="39891" xml_f="39892" txt_i="13860" txt_f="13861">3</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="39940" xml_f="39941" txt_i="13861" txt_f="13862">4</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="39989" xml_f="39990" txt_i="13862" txt_f="13863">5</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="40038" xml_f="40039" txt_i="13863" txt_f="13864">6</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="40109" xml_f="40110" txt_i="13864" txt_f="13865">X</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="40453" xml_f="40460" txt_i="13872" txt_f="13879"> Nausea</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="40803" xml_f="40808" txt_i="13886" txt_f="13891">  Yes</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="40856" xml_f="40864" txt_i="13892" txt_f="13900">0 (0.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="40912" xml_f="40920" txt_i="13901" txt_f="13909">0 (0.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="40968" xml_f="40976" txt_i="13910" txt_f="13918">0 (0.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="41024" xml_f="41032" txt_i="13919" txt_f="13927">0 (0.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="41080" xml_f="41089" txt_i="13928" txt_f="13937">3 (10.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="41137" xml_f="41145" txt_i="13938" txt_f="13946">2 (6.67)</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="41200" xml_f="41204" txt_i="13947" txt_f="13951">  No</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="41252" xml_f="41263" txt_i="13952" txt_f="13963">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="41311" xml_f="41322" txt_i="13964" txt_f="13975">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="41370" xml_f="41381" txt_i="13976" txt_f="13987">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="41429" xml_f="41440" txt_i="13988" txt_f="13999">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="41488" xml_f="41498" txt_i="14000" txt_f="14010">27 (90.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="41546" xml_f="41556" txt_i="14011" txt_f="14021">28 (93.33)</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="41611" xml_f="41620" txt_i="14022" txt_f="14031"> Vomiting</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="41963" xml_f="41968" txt_i="14038" txt_f="14043">  Yes</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="42016" xml_f="42024" txt_i="14044" txt_f="14052">0 (0.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="42072" xml_f="42080" txt_i="14053" txt_f="14061">0 (0.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="42128" xml_f="42136" txt_i="14062" txt_f="14070">0 (0.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="42184" xml_f="42192" txt_i="14071" txt_f="14079">0 (0.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="42240" xml_f="42248" txt_i="14080" txt_f="14088">2 (6.67)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="42296" xml_f="42303" txt_i="14089" txt_f="14096">0 (0.00</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="42358" xml_f="42362" txt_i="14097" txt_f="14101">  No</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="42410" xml_f="42421" txt_i="14102" txt_f="14113">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="42469" xml_f="42480" txt_i="14114" txt_f="14125">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="42528" xml_f="42539" txt_i="14126" txt_f="14137">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="42587" xml_f="42598" txt_i="14138" txt_f="14149">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="42646" xml_f="42656" txt_i="14150" txt_f="14160">28 (93.33)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="42704" xml_f="42715" txt_i="14161" txt_f="14172">30 (100.00)</offsets></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="42765" xml_f="42910" txt_i="14173" txt_f="14318">Nausea was noted after 5 out of 180 drug X doses while vomiting was noted after 2 out of 180 drug X doses. PONV: Postoperative nausea or vomiting</offsets></p></fn></table-wrap-foot></table-wrap><p><offsets xml_i="42953" xml_f="43041" txt_i="14319" txt_f="14407">As per the Pearson Chi-square and Fisher's exact tests, for the analysis of (PONV), the </offsets><italic><offsets xml_i="43049" xml_f="43050" txt_i="14407" txt_f="14408">P</offsets></italic><offsets xml_i="43059" xml_f="43071" txt_i="14408" txt_f="14417"> &lt; 0.05 [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="43103" xml_f="43110" txt_i="14417" txt_f="14424">Table 1</offsets></xref><offsets xml_i="43117" xml_f="43211" txt_i="14424" txt_f="14518">]. The Mantel–Haenszel 95% confidence interval of the OR was between 1.20 and 15.60 for PONV [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="43243" xml_f="43250" txt_i="14518" txt_f="14525">Table 2</offsets></xref><offsets xml_i="43257" xml_f="43259" txt_i="14525" txt_f="14527">].</offsets></p><p><offsets xml_i="43266" xml_f="43437" txt_i="14528" txt_f="14699">As per our modified GCS, all patients in tapentadol group had spontaneous eye opening while after 8 out of 180 tramadol doses, there was “eye opening” to speech stimulus [</offsets><xref ref-type="table" rid="T10"><offsets xml_i="43470" xml_f="43478" txt_i="14699" txt_f="14707">Table 10</offsets></xref><offsets xml_i="43485" xml_f="43487" txt_i="14707" txt_f="14709">].</offsets></p><table-wrap id="T10" position="float"><label><offsets xml_i="43536" xml_f="43544" txt_i="14710" txt_f="14718">Table 10</offsets></label><caption><p><offsets xml_i="43564" xml_f="43585" txt_i="14718" txt_f="14739">Modified GCS findings</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" valign="top" colspan="1"><offsets xml_i="43701" xml_f="43705" txt_i="14740" txt_f="14744">Drug</offsets></th><th align="center" colspan="6" rowspan="1"><offsets xml_i="43753" xml_f="43759" txt_i="14744" txt_f="14750">Dose (</offsets><italic><offsets xml_i="43767" xml_f="43768" txt_i="14750" txt_f="14751">n</offsets></italic><offsets xml_i="43777" xml_f="43782" txt_i="14751" txt_f="14756"> (%))</offsets></th></tr><tr><th align="center" colspan="7" rowspan="1"><hr></hr></th></tr><tr><th align="center" rowspan="1" colspan="1"><offsets xml_i="43905" xml_f="43906" txt_i="14756" txt_f="14757">1</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="43954" xml_f="43955" txt_i="14757" txt_f="14758">2</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="44003" xml_f="44004" txt_i="14758" txt_f="14759">3</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="44052" xml_f="44053" txt_i="14759" txt_f="14760">4</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="44101" xml_f="44102" txt_i="14760" txt_f="14761">5</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="44150" xml_f="44151" txt_i="14761" txt_f="14762">6</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="44221" xml_f="44222" txt_i="14762" txt_f="14763">Y</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="44565" xml_f="44577" txt_i="14770" txt_f="14782"> Eye opening</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="44920" xml_f="44931" txt_i="14789" txt_f="14800">  To speech</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="44979" xml_f="44987" txt_i="14801" txt_f="14809">1 (3.33)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="45035" xml_f="45043" txt_i="14810" txt_f="14818">2 (6.67)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="45091" xml_f="45100" txt_i="14819" txt_f="14828">3 (10.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="45148" xml_f="45156" txt_i="14829" txt_f="14837">0 (0.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="45204" xml_f="45212" txt_i="14838" txt_f="14846">1 (3.33)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="45260" xml_f="45268" txt_i="14847" txt_f="14855">1 (3.33)</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="45323" xml_f="45336" txt_i="14856" txt_f="14869">  Spontaneous</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="45384" xml_f="45394" txt_i="14870" txt_f="14880">29 (96.67)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="45442" xml_f="45452" txt_i="14881" txt_f="14891">28 (93.33)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="45500" xml_f="45510" txt_i="14892" txt_f="14902">27 (90.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="45558" xml_f="45569" txt_i="14903" txt_f="14914">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="45617" xml_f="45627" txt_i="14915" txt_f="14925">29 (96.67)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="45675" xml_f="45685" txt_i="14926" txt_f="14936">29 (96.67)</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="45740" xml_f="45756" txt_i="14937" txt_f="14953"> Verbal response</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="46099" xml_f="46114" txt_i="14960" txt_f="14975">  Obeys command</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="46162" xml_f="46173" txt_i="14976" txt_f="14987">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="46221" xml_f="46232" txt_i="14988" txt_f="14999">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="46280" xml_f="46291" txt_i="15000" txt_f="15011">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="46339" xml_f="46350" txt_i="15012" txt_f="15023">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="46398" xml_f="46409" txt_i="15024" txt_f="15035">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="46457" xml_f="46468" txt_i="15036" txt_f="15047">30 (100.00)</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="46523" xml_f="46524" txt_i="15048" txt_f="15049">X</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="46867" xml_f="46879" txt_i="15056" txt_f="15068"> Eye opening</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="47222" xml_f="47235" txt_i="15075" txt_f="15088">  Spontaneous</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="47283" xml_f="47294" txt_i="15089" txt_f="15100">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="47342" xml_f="47353" txt_i="15101" txt_f="15112">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="47401" xml_f="47412" txt_i="15113" txt_f="15124">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="47460" xml_f="47471" txt_i="15125" txt_f="15136">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="47519" xml_f="47530" txt_i="15137" txt_f="15148">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="47578" xml_f="47589" txt_i="15149" txt_f="15160">30 (100.00)</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="47644" xml_f="47660" txt_i="15161" txt_f="15177"> Verbal response</offsets></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="48003" xml_f="48018" txt_i="15184" txt_f="15199">  Obeys command</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="48066" xml_f="48077" txt_i="15200" txt_f="15211">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="48125" xml_f="48136" txt_i="15212" txt_f="15223">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="48184" xml_f="48195" txt_i="15224" txt_f="15235">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="48243" xml_f="48254" txt_i="15236" txt_f="15247">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="48302" xml_f="48313" txt_i="15248" txt_f="15259">30 (100.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="48361" xml_f="48372" txt_i="15260" txt_f="15271">30 (100.00)</offsets></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="48422" xml_f="48573" txt_i="15272" txt_f="15423">Eye opening and verbal response between Group X and Group Y are compared after each of the 6 doses which the patients received. GCS: Glasgow Coma Scale</offsets></p></fn></table-wrap-foot></table-wrap><p><offsets xml_i="48616" xml_f="48820" txt_i="15424" txt_f="15628">Rescue analgesia was provided the moment pain score reached 6 (moderate pain). Rescue analgesia was administered to 6 out of 30 patients in tramadol group versus 3 out of 30 patients in tapentadol group [</offsets><xref ref-type="table" rid="T11"><offsets xml_i="48853" xml_f="48861" txt_i="15628" txt_f="15636">Table 11</offsets></xref><offsets xml_i="48868" xml_f="48873" txt_i="15636" txt_f="15641"> and </offsets><xref ref-type="fig" rid="F5"><offsets xml_i="48903" xml_f="48911" txt_i="15641" txt_f="15649">Figure 5</offsets></xref><offsets xml_i="48918" xml_f="48920" txt_i="15649" txt_f="15651">].</offsets></p><table-wrap id="T11" position="float"><label><offsets xml_i="48969" xml_f="48977" txt_i="15652" txt_f="15660">Table 11</offsets></label><caption><p><offsets xml_i="48997" xml_f="49013" txt_i="15660" txt_f="15676">Rescue analgesia</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3" valign="top" colspan="1"><offsets xml_i="49129" xml_f="49145" txt_i="15677" txt_f="15693">Rescue analgesia</offsets></th><th align="center" colspan="2" rowspan="1"><offsets xml_i="49193" xml_f="49199" txt_i="15693" txt_f="15699">Drug (</offsets><italic><offsets xml_i="49207" xml_f="49208" txt_i="15699" txt_f="15700">n</offsets></italic><offsets xml_i="49217" xml_f="49222" txt_i="15700" txt_f="15705"> (%))</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="49270" xml_f="49295" txt_i="15705" txt_f="15730">Binomial test Significant</offsets></th></tr><tr><th align="center" colspan="2" rowspan="1"><hr></hr></th></tr><tr><th align="center" rowspan="1" colspan="1"><offsets xml_i="49418" xml_f="49419" txt_i="15730" txt_f="15731">Y</offsets></th><th align="center" rowspan="1" colspan="1"><offsets xml_i="49467" xml_f="49468" txt_i="15731" txt_f="15732">X</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="49538" xml_f="49541" txt_i="15732" txt_f="15735">Yes</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="49589" xml_f="49598" txt_i="15736" txt_f="15745">6 (20.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="49646" xml_f="49655" txt_i="15746" txt_f="15755">3 (10.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="49703" xml_f="49708" txt_i="15756" txt_f="15761">0.508</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="49763" xml_f="49765" txt_i="15762" txt_f="15764">No</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="49813" xml_f="49823" txt_i="15765" txt_f="15775">24 (80.00)</offsets></td><td align="center" rowspan="1" colspan="1"><offsets xml_i="49871" xml_f="49881" txt_i="15776" txt_f="15786">27 (90.00)</offsets></td><td align="center" rowspan="1" colspan="1"></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="49979" xml_f="50073" txt_i="15788" txt_f="15882">3 out of 30 patients in Group X versus 6 out of 30 patients in Group Y needed rescue analgesia</offsets></p></fn></table-wrap-foot></table-wrap><fig id="F5" position="float"><label><offsets xml_i="50150" xml_f="50158" txt_i="15883" txt_f="15891">Figure 5</offsets></label><caption><p><offsets xml_i="50178" xml_f="50280" txt_i="15891" txt_f="15993">Rescue analgesia was needed for 3 out of 30 patients in Group X versus 6 out of 30 patients in Group Y</offsets></p></caption><graphic xlink:href="ACA-18-352-g005"></graphic></fig><p><offsets xml_i="50351" xml_f="50502" txt_i="15994" txt_f="16145">Bilevel positive airway pressure (BIPAP) ventilation was used in three patients in tramadol group versus two patients in tapentadol group temporarily [</offsets><xref ref-type="fig" rid="F6"><offsets xml_i="50532" xml_f="50540" txt_i="16145" txt_f="16153">Figure 6</offsets></xref><offsets xml_i="50547" xml_f="50607" txt_i="16153" txt_f="16213">] in the form of noninvasive ventilation with the face mask.</offsets></p><fig id="F6" position="float"><label><offsets xml_i="50648" xml_f="50656" txt_i="16214" txt_f="16222">Figure 6</offsets></label><caption><p><offsets xml_i="50676" xml_f="50794" txt_i="16222" txt_f="16340">Bilevel positive airway pressure was needed for 2 out of 30 patients in Group X versus 3 out of 30 patients in Group Y</offsets></p></caption><graphic xlink:href="ACA-18-352-g006"></graphic></fig><p><offsets xml_i="50865" xml_f="50966" txt_i="16341" txt_f="16442">In both groups, epicardial ventricular pacing was used for a few hours in 2 out of 30 patients each [</offsets><xref ref-type="fig" rid="F7"><offsets xml_i="50996" xml_f="51004" txt_i="16442" txt_f="16450">Figure 7</offsets></xref><offsets xml_i="51011" xml_f="51013" txt_i="16450" txt_f="16452">].</offsets></p><fig id="F7" position="float"><label><offsets xml_i="51054" xml_f="51062" txt_i="16453" txt_f="16461">Figure 7</offsets></label><caption><p><offsets xml_i="51082" xml_f="51148" txt_i="16461" txt_f="16527">Two out of 30 patients in both the groups needed epicardial pacing</offsets></p></caption><graphic xlink:href="ACA-18-352-g007"></graphic></fig><p><offsets xml_i="51219" xml_f="51337" txt_i="16528" txt_f="16646">One patient in tramadol group had Intensive Care Unit (ICU) related psychosis after the administration of the final (6</offsets><sup><offsets xml_i="51342" xml_f="51344" txt_i="16646" txt_f="16648">th</offsets></sup><offsets xml_i="51350" xml_f="51552" txt_i="16648" txt_f="16850">) dose. None of the patients in tapentadol group had any form of psychosis. Otherwise, all patients in both groups were well oriented as far as a verbal response (as per our modified GCS) is concerned [</offsets><xref ref-type="fig" rid="F8"><offsets xml_i="51582" xml_f="51590" txt_i="16850" txt_f="16858">Figure 8</offsets></xref><offsets xml_i="51597" xml_f="51599" txt_i="16858" txt_f="16860">].</offsets></p><fig id="F8" position="float"><label><offsets xml_i="51640" xml_f="51648" txt_i="16861" txt_f="16869">Figure 8</offsets></label><caption><p><offsets xml_i="51668" xml_f="51744" txt_i="16869" txt_f="16945">One out of 30 patients in Group Y had psychosis while none had it in Group X</offsets></p></caption><graphic xlink:href="ACA-18-352-g008"></graphic></fig></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="51864" xml_f="51874" txt_i="16947" txt_f="16957">DISCUSSION</offsets></title><p><offsets xml_i="51885" xml_f="51974" txt_i="16958" txt_f="17047">Tramadol has been used commonly for postoperative analgesia following various surgeries.[</offsets><xref rid="ref2" ref-type="bibr"><offsets xml_i="52007" xml_f="52008" txt_i="17047" txt_f="17048">2</offsets></xref><offsets xml_i="52015" xml_f="52077" txt_i="17048" txt_f="17110">] It has an oral bioavailability of 95% after multiple doses.[</offsets><xref rid="ref2" ref-type="bibr"><offsets xml_i="52110" xml_f="52111" txt_i="17110" txt_f="17111">2</offsets></xref><offsets xml_i="52118" xml_f="52182" txt_i="17111" txt_f="17175">] It is a prodrug whose active metabolite is desmethyltramadol,[</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="52215" xml_f="52216" txt_i="17175" txt_f="17176">3</offsets></xref><offsets xml_i="52223" xml_f="52538" txt_i="17176" txt_f="17491">] and its onset of action is within 60 min. It is mainly metabolized by cyp450. Poor metabolizers do not get good analgesia. It has mu agonist and very less norepinephrine reuptake inhibition properties. It is 85% metabolized by the liver, 85% excreted by the kidneys, and has an elimination half-life of about 8 h.</offsets></p><p><offsets xml_i="52545" xml_f="52802" txt_i="17492" txt_f="17749">In contrast, tapentadol is an active drug, which is metabolized by glucuronidation. It has a quicker onset of 32 min as compared with that of tramadol. It has no cyp450 interaction and has much greater norepinephrine reuptake inhibition besides mu agonist.[</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="52835" xml_f="52836" txt_i="17749" txt_f="17750">3</offsets></xref><offsets xml_i="52843" xml_f="52950" txt_i="17750" txt_f="17857">] It is metabolized 70% by the liver, 95% excreted by the kidneys, and has an elimination half-life of 4 h.</offsets></p><p><offsets xml_i="52957" xml_f="53053" txt_i="17858" txt_f="17954">A thorough understanding of the neurophysiology of pain is essential for its proper management.[</offsets><xref rid="ref4" ref-type="bibr"><offsets xml_i="53086" xml_f="53087" txt_i="17954" txt_f="17955">4</offsets></xref><offsets xml_i="53094" xml_f="53277" txt_i="17955" txt_f="18138">] Different groups of analgesics such as NSAIDs and local anesthetics have been used for pain relief. Tramadol has been stated to be as effective and safe as compared with ibuprofen.[</offsets><xref rid="ref5" ref-type="bibr"><offsets xml_i="53310" xml_f="53311" txt_i="18138" txt_f="18139">5</offsets></xref><offsets xml_i="53318" xml_f="53345" txt_i="18139" txt_f="18166">] In their study, Banerjee </offsets><italic><offsets xml_i="53353" xml_f="53358" txt_i="18166" txt_f="18171">et al</offsets></italic><offsets xml_i="53367" xml_f="53553" txt_i="18171" txt_f="18357">. have stated that the need for “rescue medication” was lesser with tramadol. In another study, tramadol was found to be equally effective as ketorolac in the first 6 h postoperatively.[</offsets><xref rid="ref6" ref-type="bibr"><offsets xml_i="53586" xml_f="53587" txt_i="18357" txt_f="18358">6</offsets></xref><offsets xml_i="53594" xml_f="53925" txt_i="18358" txt_f="18689">] We used paracetamol regularly in our study while we did not use NSAIDs on a regular basis. NSAIDs have been implicated to cause other side effects such as gastritis and renal dysfunction. Tapentadol and NSAIDs belong to a different group of drugs. They have different side effects and so are difficult to compare with each other.</offsets></p><p><offsets xml_i="53932" xml_f="53990" txt_i="18690" txt_f="18748">Pregabalin too has been used for postoperative analgesia.[</offsets><xref rid="ref7" ref-type="bibr"><offsets xml_i="54023" xml_f="54024" txt_i="18748" txt_f="18749">7</offsets></xref><xref rid="ref8" ref-type="bibr"><offsets xml_i="54064" xml_f="54065" txt_i="18749" txt_f="18750">8</offsets></xref><xref rid="ref9" ref-type="bibr"><offsets xml_i="54105" xml_f="54106" txt_i="18750" txt_f="18751">9</offsets></xref><offsets xml_i="54113" xml_f="54154" txt_i="18751" txt_f="18792">] We did not use pregabalin in our study.</offsets></p><p><offsets xml_i="54161" xml_f="54382" txt_i="18793" txt_f="19014">Tapentadol has norepinephrine reuptake inhibition properties. Due to its synergistic effects with mu agonist, it leads to “opioid sparing” and decreases the gastrointestinal side effects besides providing good analgesia.[</offsets><xref rid="ref10" ref-type="bibr"><offsets xml_i="54416" xml_f="54418" txt_i="19014" txt_f="19016">10</offsets></xref><offsets xml_i="54425" xml_f="54598" txt_i="19016" txt_f="19189">] The above mechanisms could explain as to why we obtained better analgesia “at 3 h after the drug dose” with tapentadol as compared with tramadol (mean VAS 2.68 vs. 3.91) [</offsets><xref ref-type="table" rid="T6"><offsets xml_i="54630" xml_f="54637" txt_i="19189" txt_f="19196">Table 6</offsets></xref><offsets xml_i="54644" xml_f="54646" txt_i="19196" txt_f="19198">].</offsets></p><p><offsets xml_i="54653" xml_f="54970" txt_i="19199" txt_f="19516">“Rescue analgesia” was needed for 6 out of 30 patients in tramadol group versus 3 out of 30 patients in tapentadol group. Rescue analgesia was provided by using IV ketorolac 30 mg. Thus, 51 out of 60 patients studied (85%) did not need rescue analgesia since the pain was managed effectively by using the study drugs.</offsets></p><p><offsets xml_i="54977" xml_f="55049" txt_i="19517" txt_f="19589">In our study, tramadol caused a little more drowsiness than tapentadol [</offsets><xref ref-type="table" rid="T10"><offsets xml_i="55082" xml_f="55090" txt_i="19589" txt_f="19597">Table 10</offsets></xref><offsets xml_i="55097" xml_f="55170" txt_i="19597" txt_f="19670">]. Tapentadol has been reported to cause lesser confusion than tramadol.[</offsets><xref rid="ref11" ref-type="bibr"><offsets xml_i="55204" xml_f="55206" txt_i="19670" txt_f="19672">11</offsets></xref><offsets xml_i="55213" xml_f="55338" txt_i="19672" txt_f="19797">] None of the patients who received tapentadol had ICU psychosis. One patient in tramadol group had ICU psychosis after the 6</offsets><sup><offsets xml_i="55343" xml_f="55345" txt_i="19797" txt_f="19799">th</offsets></sup><offsets xml_i="55351" xml_f="55397" txt_i="19799" txt_f="19845"> dose, which responded to antipsychotic drugs.</offsets></p><p><offsets xml_i="55404" xml_f="55502" txt_i="19846" txt_f="19944">It has been advised not to use tapentadol when the patient has CNS and/or respiratory depression.[</offsets><xref rid="ref12" ref-type="bibr"><offsets xml_i="55536" xml_f="55538" txt_i="19944" txt_f="19946">12</offsets></xref><offsets xml_i="55545" xml_f="56391" txt_i="19946" txt_f="20792">] Tapentadol has no active metabolites. The respiratory rate and oxygen saturation were similar between the two groups. BIPAP was used prophylactically in two patients temporarily who received tapentadol as compared with three patients who received tramadol when mild lung basal atelectatic changes were seen on the chest roentgenogram. None of the patients needed reintubation since we could obtain oxygen saturation of 95% or above. PCO2 levels were not compared for the six doses between the two drugs. The arterial blood gas (ABG) samples taken in the ICU were randomly based on multiple system factors like “during hypotension” or oliguria. ABG sampling was not consistent with the timing of the drug dose. E.g., one ABG sample was taken just after the drug was administered while another sample was taken during the peak effect of the drug.</offsets></p><p><offsets xml_i="56398" xml_f="56815" txt_i="20793" txt_f="21210">IV opioids have a greater risk of CNS and/or respiratory depression and aspiration as compared with oral opioids due to their sudden increased blood and cerebrospinal fluid levels. Besides, there can be mechanical or technical problems with infusion (syringe) pumps or PCA pumps. We gave titrated IV 3 or 4 mg morphine boluses if needed, as analgesics before extubation, that is, before the commencement of our study.</offsets></p><p><offsets xml_i="56822" xml_f="56894" txt_i="21211" txt_f="21283">Tapentadol has better gastrointestinal tolerability than other opioids.[</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="56928" xml_f="56930" txt_i="21283" txt_f="21285">13</offsets></xref><offsets xml_i="56937" xml_f="56985" txt_i="21285" txt_f="21333">] The incidence of PONV ranges from 12% to 38%.[</offsets><xref rid="ref14" ref-type="bibr"><offsets xml_i="57019" xml_f="57021" txt_i="21333" txt_f="21335">14</offsets></xref><offsets xml_i="57028" xml_f="57449" txt_i="21335" txt_f="21756">] Risk factors for PONV include a history of PONV, female sex, nonsmokers, postoperative opioids, use of neostigmine, inhalational agents, and a certain type of surgeries. The use of continuous positive airway pressure mask may have produced gastric distension and PONV. Tapentadol patients had lesser PONV than tramadol group in our study. PONV was managed by using IV ondansetron, metoclopramide, and dexamethasone as 1</offsets><sup><offsets xml_i="57454" xml_f="57456" txt_i="21756" txt_f="21758">st</offsets></sup><offsets xml_i="57462" xml_f="57465" txt_i="21758" txt_f="21761">, 2</offsets><sup><offsets xml_i="57470" xml_f="57472" txt_i="21761" txt_f="21763">nd</offsets></sup><offsets xml_i="57478" xml_f="57485" txt_i="21763" txt_f="21770">, and 3</offsets><sup><offsets xml_i="57490" xml_f="57492" txt_i="21770" txt_f="21772">rd</offsets></sup><offsets xml_i="57498" xml_f="57689" txt_i="21772" txt_f="21963"> line of treatment, respectively. One patient in tramadol group had constipation, which was treated with 10 mg bisacodyl oral tablet while no patient in tapentadol group had any constipation.</offsets></p><p><offsets xml_i="57696" xml_f="57870" txt_i="21964" txt_f="22138">The temperature reading difference was not statistically significant between the two groups. The Postoperative fever could be due to infection, inflammation, drug fever, etc.</offsets></p><p><offsets xml_i="57877" xml_f="58131" txt_i="22139" txt_f="22393">Four out of thirty patients in each group had atrial fibrillation (AF) at some point of time, which was treated with titrated IV metoprolol and/or IV amiodarone followed by oral antiarrhythmics. Opioids have traditionally not been implicated to cause AF.</offsets></p><p><offsets xml_i="58138" xml_f="58659" txt_i="22394" txt_f="22915">Two patients in each group needed temporary epicardial pacing for better hemodynamics. As stated earlier, most cardiac patients were receiving beta-blockers in the postoperative period for prevention of “AF with the uncontrolled high ventricular rate.” Although opioids have been known to cause bradycardia, it is not clear from our study whether tapentadol or tramadol causes significant bradycardia on their own. These patients were not symptomatic; otherwise, they responded to temporary ventricular epicardial pacing.</offsets></p><p><offsets xml_i="58666" xml_f="58762" txt_i="22916" txt_f="23012">Tapentadol extended-release tablets allow for twice daily dosing and better patient compliance.[</offsets><xref rid="ref15" ref-type="bibr"><offsets xml_i="58796" xml_f="58798" txt_i="23012" txt_f="23014">15</offsets></xref><offsets xml_i="58805" xml_f="58994" txt_i="23014" txt_f="23203">] We used both the drugs thrice daily and the creatinine levels of both groups were similar. One patient in tramadol group had a rise in creatinine level from 1.35 to 1.71 mg/dL after the 5</offsets><sup><offsets xml_i="58999" xml_f="59001" txt_i="23203" txt_f="23205">th</offsets></sup><offsets xml_i="59007" xml_f="59178" txt_i="23205" txt_f="23376"> dose. The patient needed dopamine at 3–5 mcg/kg/min and frusemide infusion, which were weaned off later. However, that patient tolerated tramadol and was awake and alert.</offsets></p><p><offsets xml_i="59185" xml_f="59408" txt_i="23377" txt_f="23600">None of the patients had urinary retention. None of the patients had jaundice though bilirubin levels were not regularly recorded for the study. The dose of paracetamol, which we used, is not known to be a hepatotoxic dose.</offsets></p><p><offsets xml_i="59415" xml_f="59546" txt_i="23601" txt_f="23732">One patient in tramadol group had a re-exploration for pericardial effusion drainage following aortic valve replacement after the 4</offsets><sup><offsets xml_i="59551" xml_f="59553" txt_i="23732" txt_f="23734">th</offsets></sup><offsets xml_i="59559" xml_f="59646" txt_i="23734" txt_f="23821"> dose of the drug. However, we continued the study after the extubation (postdrainage).</offsets></p><p><offsets xml_i="59653" xml_f="59805" txt_i="23822" txt_f="23974">None of the patients had any seizures or itching. Opioids, particularly after the intrathecal route of administration, have been known to cause itching.</offsets></p><p><offsets xml_i="59812" xml_f="59972" txt_i="23975" txt_f="24135">There were no deaths during the study. Those patients who were on high inotropic support and/or IABP at the time of extubation had been excluded from the study.</offsets></p><sec id="sec2-4"><title><offsets xml_i="60000" xml_f="60024" txt_i="24136" txt_f="24160">Limitations of our study</offsets></title><p><offsets xml_i="60035" xml_f="60036" txt_i="24161" txt_f="24162">
</offsets><list list-type="bullet"><list-item><p><offsets xml_i="60075" xml_f="60362" txt_i="24162" txt_f="24449">We could not exactly time Romson's respirometer with the drug doses in spite of good physiotherapy, which provided valuable deep breathing exercises, use of acapella, etc. Respiratory volumes (in milliliters) from Romson's respirometer needs to be recorded and analyzed in future studies</offsets></p></list-item><list-item><p><offsets xml_i="60392" xml_f="60511" txt_i="24450" txt_f="24566">We did not study geriatric patients (&gt;65 years) since the safety of tapentadol in this age group is not established.</offsets></p></list-item></list><offsets xml_i="60534" xml_f="60535" txt_i="24567" txt_f="24568">
</offsets></p><p><offsets xml_i="60542" xml_f="60708" txt_i="24569" txt_f="24735">We conclude that in the patients who are receiving paracetamol, the drug tapentadol is a better analgesic than tramadol for adult patients undergoing cardiac surgery.</offsets></p></sec><sec id="sec2-5"><title><offsets xml_i="60742" xml_f="60775" txt_i="24737" txt_f="24770">Financial support and sponsorship</offsets></title><p><offsets xml_i="60786" xml_f="60859" txt_i="24771" txt_f="24844">Funding was provided solely by Chettinad Hospital and Research Institute.</offsets></p></sec><sec id="sec2-6"><title><offsets xml_i="60893" xml_f="60913" txt_i="24846" txt_f="24866">Conflict of interest</offsets></title><p><offsets xml_i="60924" xml_f="60958" txt_i="24867" txt_f="24901">There are no conflict of interest.</offsets></p></sec></sec></body><back><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fidman</surname><given-names>B</given-names></name><name><surname>Nogid</surname><given-names>A</given-names></name></person-group><article-title>Role of tapentadol immediate release in the management of moderate to severe pain</article-title><source>J Pharm Ther</source><year>2010</year><volume>35</volume><fpage>330</fpage><lpage>3</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duthie</surname><given-names>DJ</given-names></name></person-group><article-title>Remifentanil and tramadol</article-title><source>Br J Anaesth</source><year>1998</year><volume>81</volume><fpage>51</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9771272</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>DR</given-names></name><name><surname>Nag</surname><given-names>K</given-names></name><name><surname>Sheti</surname><given-names>AN</given-names></name><name><surname>Krishnaveni</surname><given-names>N</given-names></name></person-group><article-title>Tapentadol hydrochloride: A novel analgesic</article-title><source>Saudi J Anaesth</source><year>2013</year><volume>7</volume><fpage>322</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">24015138</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>MJ</given-names></name><name><surname>Schecter</surname><given-names>WP</given-names></name></person-group><article-title>Perioperative pain control: A strategy for management</article-title><source>Surg Clin North Am</source><year>2005</year><volume>85</volume><fpage>1243</fpage><lpage>57, xi</lpage><pub-id pub-id-type="pmid">16326205</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>M</given-names></name><name><surname>Bhaumik</surname><given-names>DJ</given-names></name><name><surname>Ghosh</surname><given-names>AK</given-names></name></person-group><article-title>A comparative study of oral tramadol and ibuprofen in postoperative pain in operations of lower abdomen</article-title><source>J Indian Med Assoc</source><year>2011</year><volume>109</volume><fpage>619</fpage><lpage>22, 626</lpage><pub-id pub-id-type="pmid">22480093</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>H</given-names></name><name><surname>Khan</surname><given-names>FA</given-names></name></person-group><article-title>A double-blind, placebo-controlled randomized comparison of pre and postoperative administration of ketorolac and tramadol for dental extraction pain</article-title><source>J Anaesthesiol Clin Pharmacol</source><year>2012</year><volume>28</volume><fpage>221</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">22557747</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>S</given-names></name><name><surname>Jagadeesh</surname><given-names>AM</given-names></name></person-group><article-title>Efficacy of perioperative pregabalin in acute and chronic postoperative pain after off pump coronary artery bypass – A random double blind placebo controlled trial</article-title><source>Ann Card Anaesth</source><year>2013</year><fpage>180</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">23816671</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>PN</given-names></name></person-group><article-title></article-title><source>Ann Card Anaesth</source><year>2013</year><volume>16</volume><fpage>180</fpage><pub-id pub-id-type="pmid">23971137</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pradeep Kumar</surname><given-names>K</given-names></name><name><surname>Kulkarni</surname><given-names>DK</given-names></name><name><surname>Gurujala</surname><given-names>I</given-names></name><name><surname>Gopinath</surname><given-names>R</given-names></name></person-group><article-title>Pregabalin versus tramadol for postoperative pain management in patients undergoing lumbar laminectomy: A random double blinded placebo controlled study</article-title><source>J Pain Res 2013</source><year>2013</year><fpage>471</fpage><lpage>8</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzschentke</surname><given-names>TM</given-names></name><name><surname>Christoph</surname><given-names>T</given-names></name><name><surname>Kögel</surname><given-names>B</given-names></name><name><surname>Schiene</surname><given-names>K</given-names></name><name><surname>Hennies</surname><given-names>HH</given-names></name><name><surname>Englberger</surname><given-names>W</given-names></name><etal></etal></person-group><article-title>(-)-(1R,2R)-3- (3-dimethylamino-1-ethyl-2-methyl-propyl)- phenol hydrochloride (tapentadol HCl): A novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties</article-title><source>J Pharmacol Exp Ther</source><year>2007</year><volume>323</volume><fpage>265</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">17656655</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Power</surname><given-names>I</given-names></name></person-group><article-title>An update on analgesics</article-title><source>Br J Anaesth</source><year>2011</year><volume>107</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">21624966</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendis</surname><given-names>V</given-names></name></person-group><article-title>Role of tapentadol in pain management</article-title><source>Br J Hosp Med (Lond)</source><year>2012</year><volume>73</volume><fpage>143</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22411644</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vadivelu</surname><given-names>N</given-names></name><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Narayan</surname><given-names>D</given-names></name></person-group><article-title>Recent advances in postoperative pain management</article-title><source>Yale J Biol Med</source><year>2010</year><volume>83</volume><fpage>11</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">20351978</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrakantan</surname><given-names>A</given-names></name><name><surname>Glass</surname><given-names>PS</given-names></name></person-group><article-title>Multimodal therapies for postoperative nausea and vomiting, and pain</article-title><source>Br J Anaesth</source><year>2011</year><volume>107</volume><issue>Suppl 1</issue><fpage>i27</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">22156268</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vadivelu</surname><given-names>N</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Mirante</surname><given-names>B</given-names></name><name><surname>Jacoby</surname><given-names>M</given-names></name><name><surname>Braveman</surname><given-names>FR</given-names></name><name><surname>Hines</surname><given-names>RL</given-names></name><etal></etal></person-group><article-title>Patient considerations in the use of tapentadol for moderate to severe pain</article-title><source>Drug Healthc Patient Saf</source><year>2013</year><volume>5</volume><fpage>151</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">23861601</pub-id></element-citation></ref></ref-list></back></article>